Technology

Viral Vaccines Market, Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Viral Vaccines in global, including the following market information:

  • Global Viral Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global Viral Vaccines Market Sales, 2017-2022, 2023-2028, (K MT)
  • Global top five Viral Vaccines companies in 2021 (%)

 

The global Viral Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Attenuated Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Viral Vaccines include GSK, Merck, Novartis, Pfizer, Sanofi, Bayer, Zoetis, AstraZeneca and Johnson and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Viral Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Viral Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Viral Vaccines Market Segment Percentages, by Type, 2021 (%)

  • Attenuated Vaccine
  • Inactivated Vaccine

Global Viral Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Viral Vaccines Market Segment Percentages, by Application, 2021 (%)

  • Hospital
  • Pharmaceutical Factory
  • Research Institute
  • Others

Global Viral Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Viral Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Viral Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
  • Key companies Viral Vaccines revenues share in global market, 2021 (%)
  • Key companies Viral Vaccines sales in global market, 2017-2022 (Estimated), (K MT)
  • Key companies Viral Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • GSK
  • Merck
  • Novartis
  • Pfizer
  • Sanofi
  • Bayer
  • Zoetis
  • AstraZeneca
  • Johnson
  • CSL

Table of content

1 Introduction to Research & Analysis Reports
1.1 Viral Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vaccines Overall Market Size
2.1 Global Viral Vaccines Market Size: 2021 VS 2028
2.2 Global Viral Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Viral Vaccines Sales: 2017-2028
3 Company Landscape
3.1 Top Viral Vaccines Players in Global Market
3.2 Top Global Viral Vaccines Companies Ranked by Revenue
3.3 Global Viral Vaccines Revenue by Companies
3.4 Global Viral Vaccines Sales by Companies
3.5 Global Viral Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Viral Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Viral Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Viral Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Viral Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Viral Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Viral Vaccines Market Size Markets, 2021 & 2028
4.1.2 Attenuated Vaccine

CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414

Similar Reports:

Viral Vaccines Market, Global Outlook and Forecast 2022-2028

Global Viral Vector Vaccines Market Insights and Forecast to 2028

Global Viral Vaccines Market Insights and Forecast to 2028

Global and China Viral Vector Vaccines Market Insights, Forecast to 2027

Related Articles

Back to top button